🔴 Oncolytics Biotech is trading 5% down — no confirmed catalyst

Oncolytics Biotech is trading 5.39% down at $0.60 on October 5, 2026; no confirmed catalyst has emerged.

• No clear company-specific announcement explaining the decline surfaced in the available search. The company’s latest listed releases were dated September 29 and September 28, before this session.
• Broader market data provided was mixed, offering no clear same-direction explanation for the drop.
• Available evidence does not establish that earlier company news caused the decline.